The Human Phenotype Ontology (HPO) provides the following list of features that have been reported in people with this condition. Much of the information in the HPO comes from Orphanet, a European rare disease database. If available, the list includes a rough estimate of how common a feature is (its frequency). Frequencies are based on a specific study and may not be representative of all studies. You can use the MedlinePlus Medical Dictionary for definitions of the terms below.
|Signs and Symptoms||Approximate number of patients (when available)|
|Abnormality of urine homeostasis||7.5%|
|Nausea and vomiting||7.5%|
Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.
Nonprofit support and advocacy groups bring together patients, families, medical professionals, and researchers. These groups often raise awareness, provide support, and develop patient-centered information. Many are the driving force behind research for better treatments and possible cures. They can direct people to research, resources, and services. Many groups also have experts who serve as medical advisors. Visit their website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
20th Congress of the International Organization for Mycoplasmology (IOM)
Sunday, June 1, 2014 -
Friday, June 6, 2014
Location: Federal Universidade Regional de Blumenau , Santa Catarina, Brazil
Description: The Congress provides a unique international forum to exchange scientific findings, discuss recent research progress, identify areas requiring greater emphasis, set research goals for the next biennium, recognize outstanding achievement in the field, and promote the study of mycoplasmas to young scientists. The Congress is also significant because it creates important opportunities for career development, networking and formal international recognition of early career achievements by the next generation of mycoplasmologists. Direct international exchange of new findings on the biology, epidemiology and control of these pathogens is contributing to improved diagnostics and intervention strategies necessary to reduce the substantial burden of infectious diseases involving these organisms, and helps to excite and create career opportunities for rising young biomedical scientists.
Contact: Barbara L. Mulach, Ph.D.,(301) 402-4199,firstname.lastname@example.org
Co-funding Institute(s): National Institute of Allergy and Infectious Diseases, Office of Rare Diseases Research
Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know. Submit a new question
Is there a genetic component to CAD? My mother has it so we're naturally curious. See answer
Are there any tests that can be done to identify the presence of a cold agglutinin disorder in a patient? It is helpful to know what populations of patients might have a predisposition for the disorder. However, should one identify a patient who might fall into that catagory, is there a way to identify the presence of the disorder? See answer
What is the difference between cryoglobulinemia and cold agglutinin disease? See answer